Vanguard Group Inc Aytu Biopharma, Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.15 - $4.0 $110 - $2,944	736 Added 0.08%	973,435 $184,000
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $22,435 - $448,700	-118,079 Reduced 10.83%	972,699 $180,000
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.08 $169,378 - $397,672	368,215 Added 50.96%	1,090,778 $753,000
Q1 2022 May 13, 2022	SELL	$1.08 - $1.55 $238,768 - $342,677	-221,082 Reduced 23.43%	722,563 $780,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $53,651 - $117,238	-39,742 Reduced 4.04%	943,645 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$4.73 - $7.56 $4.65 Million - $7.43 Million	983,387 New	983,387 $4.93 Million

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $111M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.